Plenary Session

FDA CBER Overview and accelerated pathways in regenerative medicine

January 23, 2018 5:30 pm - 6:45 pm

Bookmark and Share

Julie G. Allickson, PhD
Anthony Atala, MD
Arnold Caplan, PhD
Peter Marks, MD, PhD
Camillo Ricordi, MD

Keynote Speaker:
Peter Marks MD, PhD – Director, Center for Biologics Evaluation and Research U.S. Food & Drug Administration

Roundtable and Q&A

Julie G. Allickson, PhD – Director, Regenerative Medicine Clinical Center, Wake Forest University School of Medicine;

Anthony Atala, MD – Director, Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine

Arnold Caplan, PhD
Director, Skeletal Research Center
Case Western Reserve University

Camillo Ricordi, MD
Director and Chief Academic Officer
University of Miami Diabetes Research Institute